ストックスクリーナーアプリを入手
1.8997
2.56%
-0.0503
前日終値:
$1.95
開ける：
$1.88
24時間の取引高:
1.10M
Relative Volume:
0.99
時価総額：
$23.24M
収益：
$22.06M
当期純損益:
$-30.94M
株価収益率:
-0.8481
EPS:
-2.24
ネットキャッシュフロー:
$-26.70M
1週間 パフォーマンス:
+25.00%
1か月 パフォーマンス:
+46.15%
6か月 パフォーマンス:
-25.49%
1年 パフォーマンス:
-70.77%
1日の値動き範囲:
$1.86
$2.15
1週間の範囲:
$1.25
$2.57
52週間の値動き範囲:
$1.0909
$7.67
Casi Pharmaceuticals Inc Stock (CASI) Company Profile
CASI を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CASI
Casi Pharmaceuticals Inc
|
1.89 | 19.99M | 22.06M | -30.94M | -26.70M | -2.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
384.02 | 118.67B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
571.47 | 59.23B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
416.77 | 52.67B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
684.61 | 41.24B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
308.04 | 32.36B | 3.81B | -644.79M | -669.77M | -6.24 |
Casi Pharmaceuticals Inc Stock (CASI) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2021-05-18 | 開始されました | BTIG Research | Buy |
| 2021-04-26 | 開始されました | Mizuho | Buy |
| 2020-10-23 | 開始されました | Oppenheimer | Outperform |
| 2016-09-22 | 開始されました | Maxim Group | Buy |
| 2015-10-29 | 再開されました | H.C. Wainwright | Buy |
| 2015-06-23 | 開始されました | H.C. Wainwright | Buy |
すべてを表示
Casi Pharmaceuticals Inc (CASI) 最新ニュース
What makes CASI Pharmaceuticals Inc. stock price move sharplySmart Trend Analysis With Buy Point Cues - Newser
Using fundamentals and technicals on CASI Pharmaceuticals Inc.Swing Trade Timing with Daily Forecast - Newser
Is CASI Pharmaceuticals Inc. stock bottoming outEquity Signal Recap With Long-Term Summary - Newser
How to build a custom watchlist for CASI Pharmaceuticals Inc.Pattern Breakout Tracker with Screener Tools - Newser
CASI Pharmaceuticals: Will New Leadership Catalyze Growth? - StocksToTrade
Does CASI Pharmaceuticals Inc. fit your quant trading modelFree Growth Based Stock Signal Screener - Newser
CASI Pharmaceuticals stock soars after FDA clearance for transplant drug By Investing.com - Investing.com India
CASI Pharmaceuticals stock soars after FDA clearance for transplant drug - Investing.com
CASI Pharmaceuticals Receives FDA Clearance for CID-103 IND Application - TipRanks
CASI Pharmaceuticals Announces FDA Clearance of IND Application for CID-103 in Renal Allograft Antibody-Mediated Rejection (AMR) - Newswire.com
Evaluating CASI Pharmaceuticals Inc. with trendline analysisFree Quick Gain Stock Watch With Indicators - Newser
Will CASI Pharmaceuticals Inc. Stock Benefit from AI and Green Energy TrendsLong-Term Investment Strategy Impact Analysis - Newser
What are the technical indicators suggesting about CASI Pharmaceuticals Inc.Rapid-fire capital growth - Jammu Links News
What is the dividend policy of CASI Pharmaceuticals Inc. stockFree Investment Risk Control - Jammu Links News
Pattern recognition hints at CASI Pharmaceuticals Inc. upsideFree AI Driven Stock Trend Forecast - newser.com
Is CASI Pharmaceuticals Inc. still worth holding after the dipFree Entry Points For Growing Stocks - Newser
When is CASI Pharmaceuticals Inc. stock expected to show significant growthInvest smarter with high-probability setups - Jammu Links News
Why is CASI Pharmaceuticals Inc. stock attracting strong analyst attentionFree Predictions - Jammu Links News
Exit strategy if you’re trapped in CASI Pharmaceuticals Inc.Reversal Signal Prediction Based on Volume - newser.com
Is CASI Pharmaceuticals Inc. stock overvalued or undervaluedHigh-yield market plays - Jammu Links News
How to manage a losing position in CASI Pharmaceuticals Inc.Fast Entry Strategy with Price Prediction - Newser
Should I hold or sell CASI Pharmaceuticals Inc. stock in 2025Market Forecast Tips With Proven Results - Jammu Links News
CASI Pharmaceuticals Inc. Stock Chart Analysis: Bullish or Bearish Pattern FormingFree Capital Preserving Trade Plan Templates - Newser
Is it time to cut losses on CASI Pharmaceuticals Inc.Pre-Market Stock Movement Summary and Review - Newser
What the charts say about CASI Pharmaceuticals Inc. todayPrice Action Summary and Entry Strategy Guide - Newser
How CASI Pharmaceuticals Inc. stock performs during market volatilityFree Secure Return Focused Investment Plan - Newser
How does CASI Pharmaceuticals Inc. generate profit in a changing economyFinancial News Planner Backed By Experts - Jammu Links News
Can you recover from losses in CASI Pharmaceuticals Inc.Free News Based Entry Opportunity Alerts - Newser
Advanced analytics toolkit walkthrough for CASI Pharmaceuticals Inc.Long-Term Stock Growth Forecast Insights - Newser
What are CASI Pharmaceuticals Inc. company’s key revenue driversChart Pattern Insights Backed By Experts - Jammu Links News
What institutional investors are buying CASI Pharmaceuticals Inc. stockGrow your portfolio with growth-oriented stocks - Jammu Links News
What is the risk reward ratio of investing in CASI Pharmaceuticals Inc. stockBuild a diversified portfolio for sustainable growth - Jammu Links News
Casi Pharmaceuticals Inc (CASI) 財務データ
収益
当期純利益
現金流量
EPS
0.74%
0.92%
大文字化:
|
ボリューム (24 時間):